U.S. Lifts Pause, Allowing Johnson & Johnson COVID-19 Vaccinations To Resume

WASHINGTON (AP) β€” U.S. lifts pause, allowing Johnson & Johnson COVID-19 vaccinations to resume.

The CDC and FDA released a joint statement on Friday, April 23rd to say they will continue to keep a close eye on possible side effects, but for now encourage Americans to continue receiving their shots of the Janssen vaccine.

β€œAbove all else, health and safety are at the forefront of our decisions,” said CDC Director Dr. Rochelle P. Walensky. β€œOur vaccine safety systems are working. We identified exceptionally rare events – out of millions of doses of the Janssen COVID-19 administered – and we paused to examine them more carefully. As we always do, we will continue to watch all signals closely as more Americans are vaccinated. I continue to be encouraged by the growing body of real-world evidence that the authorized COVID-19 vaccines are safe and effective, and they protect people from disease, hospitalization, and death. I urge anyone with questions about the COVID-19 vaccines to speak with their healthcare provider or local public health department.”

The South Carolina Department of Health and Environmental Control responded to this announcement in a statement saying the potential benefits of the Johnson & Johnson vaccine outweigh the known and potential risks.

South Carolina health officials urge residents who have not yet received their COVID-19 vaccine to do so, and get their Janssen, Moderna, or Pfizer shots as soon as possible.

Health officials say COVID-19 vaccines are safe and effective, and they are helping save lives.